美瑞健康國際(02327.HK)盈喜:預計2023年純利約3800萬至4380萬港元
格隆匯3月22日丨美瑞健康國際(02327.HK)發佈公吿,集團預期於截至2023年12月31日止年度錄得股東應占溢利介乎約3800萬港元至4380萬港元,而2022年度則錄得股東應占溢利為約1780萬港元。
公吿表示,有關預期增加的主要原因如下:(i)得益於集團歐洲國際貿易業務的積極拓展,新能源產品採購服務收入大增,使得貿易業務的毛利大幅增長;及(ii)由於股權投資的企業收入及利潤有所增長,導致按公允價值計入損益的投資的未變現公允價值上升,而上述因素被以下不利因素部分抵銷:(iii)因為經營環境發生變化,所以集團大幅增加了貿易及其他應收款的撥備,以及因為集團將資金投入業務拓展及營運,所以利息收入減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.